...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides
【24h】

Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides

机译:抗凝血剂诱发剂的啮齿动物群体管理:朝向第三代抗凝血剂啮齿失体

获取原文
获取原文并翻译 | 示例
           

摘要

Second-generation anticoagulant rodenticides (SGARs) have been used since the 1980s for pest management. They are highly efficient even in warfarin-resistant rodents. Nevertheless, because of their tissue persistence, nontarget poisoning by SGARs is commonly described in wildlife. Due to this major problem, a new generation of anticoagulants must be developed to limit this risk. This study proposes a method of developing a new generation of anticoagulant rodenticides by revisiting the old SGARs based on the concept of stereochemistry. Each current SGAR is a mixture of diastereomers. Diastereomers of each compound were purified, and their biologic properties were compared by determining their ability to inhibit vitamin K epoxide reductase (VKOR) activity involved in the activation of vitamin K-dependent clotting factors and their toxicokinetic properties. Systematically, for each SGAR, both diastereomers are as effective in inhibiting VKOR activity. However, their toxicokinetic properties are very different, with one of the two diastereomers always more rapidly cleared than the other one. For all SGARs except flocoumafen, the less persistent diastereomer is always the less predominant isomer present in the current mixture. Therefore, the development of baits containing only the less persistent diastereomer would avoid the ecotoxicological risk associated with their use without decreasing their efficacy.
机译:自20世纪80年代以来,已经使用了第二代抗凝血剂啮齿失体(SGARS)进行害虫管理。它们即使在耐华林啮齿动物中也具有高效。然而,由于他们的组织持久性,野生动物通常用野生生物中的Nontarget中毒。由于这一主要问题,必须制定新一代的抗凝血剂以限制这种风险。本研究提出了一种通过根据立体化学的概念重新探索旧的糖类来开发新一代抗凝血剂的抗凝血剂的方法。每个当前的糖是非对映异构体的混合物。纯化每种化合物的非对映异构体,并通过确定其抑制活化维生素K依赖性凝血因子及其诱导性能的抑制维生素K环氧化物还原酶(VKOR)活性的能力来进行比较。系统地,对于每个糖,两种非对映异构体都在抑制VKOR活性方面有效。然而,它们的诱导性质是非常不同的,两种非对映异构体中的一种总是比另一个更快速地清除。对于除Flocoumafen之外的所有SGAR,较少的持续的非对映异构体始终是当前混合物中存在的较少的主要异构体。因此,仅含有较低持续的非对映异构体的诱饵的发展将避免与其使用相关的生态毒理学风险,而不会降低它们的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号